DexCom (DXCM) Soars 10% This Week: What’s Fueling the Gain?
ZacksA recent approval for DexCom’s (DXCM) new CGM device boosts the prospects of the company by broadening the targeted market. Shares gain as investors see strong potential for growth going forward.